To discover the efficient and novel drug targets in human cancers using crispr/cas screening and databases

12Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

CRISPR/Cas has emerged as an excelle nt gene-editing technology and is used worldwide for research. The CRISPR library is an ideal tool for identifying essential genes and synthetic lethality targeted for cancer therapies in human cancers. Synthetic lethality is defined as multiple genetic abnormalities that, when present individually, do not affect function or survival, but when present together, are lethal. Recently, many CRISPR libraries are available, and the latest libraries are more accurate and can be applied to few cells. However, it is easier to efficiently search for cancer targets with their own screenings by effectively using databases of CRISPR screenings, such as Depmap portal, PICKLES (Pooled In-Vitro CRISPR Knockout Library Essentiality Screens), iCSDB, Project Score database, and CRISP-view. This review will suggest recent optimal CRISPR libraries and effective databases for Novel Approaches in the Discovery and Design of Targeted Therapies.

Cite

CITATION STYLE

APA

Onishi, I., Yamamoto, K., Kinowaki, Y., Kitagawa, M., & Kurata, M. (2021, November 1). To discover the efficient and novel drug targets in human cancers using crispr/cas screening and databases. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms222212322

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free